The U.S. FDA Priority Review Voucher Read more
Counterfeit, Substandard and Generic Drugs: Distinct Definitions for Distinctly Different Problems Read more
Valganciclovir Patent Set Aside in India read MSF's statement
New MSF report shows Europe failing to pay fair share of TB research
MSF hosts malnutrition symposium in NY Read more
|
 |
|
 |
|
 |
Other Diseases
|
 |
© Juan Carlos Tomasi |
MSF has been working since 1999 with patients suffering from Chagas. This parasitical disease, found on the American continent, affects around 16 - 18 million people. New drugs and diagnostics are needed to tackle the disease, including medications adapted for children.
Click here for a slide show on Chagas
Sleeping Sickness Fact Sheet
60 million people are at risk of contracting sleeping sickness, or human African trypanosomiasis (HAT). The disease affects 36 countries across sub-Saharan Africa. Nearly eliminated in the 1960s, the disease has been making a massive comeback due to war, population movements and the collapse of health systems. Click here |
DNDi launches new malaria treatment
Co-founder of the Drugs for Neglected Diseases Initiative, MSF has been pushing for new models of medical innovation, allowing for the development of better more affordable drugs that target the diseases of the poor. Last year DNDi launched their first product, a patent free combination therapy for malaria, AS/AQ. Read more |
to read MSF's Fact Sheet on Sleeping Sickness
